Conceptos básicos del cáncer de páncreas
681 articles
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
Diabetes
If You Have Diabetes, Are You At Risk for Pancreatic Cancer? If you are living with diabetes or prediabetes, you may have heard that there is a link between diabetes and pancreatic cancer. Please be reassured that most people with diabetes do not develop pancreatic cancer. However, it is known that almost one in four […]
Man + Machine: Using Deep Learning for Early Detection of Pancreatic Cancer
Dr. Elliot Fishman is part of a team that is using artificial intelligence, or deep learning to develop techniques for early detection of pancreatic cancer.
New Study Targets Specific BRAF Mutation
One type of BRAF mutation may provide a target for treatment in pancreatic cancer patients, explains Dr. Michael Pishvaian.
Cancer Commons and xCures Hope to Use Real-World Data to Improve Care
Lola Rahib and Patrick van der Valk explain how Cancer Commons and xCures are using real-world data to improve care for future patients.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
A Second Opinion Changes the Pancreatic Cancer Game Plan
Gregg Wittman’s doctors diagnosed him with stage IV pancreatic cancer, but could never get a good biopsy; a second opinion figured out the reason.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
Most Cancer Mutations Are Random DNA Mistakes
In a large study, Dr. Bert Vogelstein of Johns Hopkins found that a majority of cancers, including pancreatic cancer, are caused by random mutations of DNA.
Immunotherapy Treatments Provide Hope to Pancreatic Cancer Patients
Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.
Surprising Clinical Trial Results in Pancreatic and Rectal Cancer
Let’s Win Scientific Advisory Board Chair Dr. Allyson Ocean explains the surprising clinical trial results in pancreatic and rectal cancers.
A Potential Role for PARP Inhibitors in Pancreatic Cancer
Dr. Michael Pishvaian leads research into the possible role of PARP inhibitors in treating pancreatic cancer patients with certain genetic mutations.
Research Updates from ASCO GI 2023
Read the latest clinical trial and research updates from the 2023 ASCO GI meeting, including a review of genetic testing uptake.
New-Onset Diabetes Plus Unintentional Weight Loss Emerging as an Important Clue In Earlier Detection
Dr. Brian Wolpin outlines the connection between unintentional weight loss, new-onset diabetes, and pancreatic cancer.
Overcoming Challenges to Vaccine Immunotherapy
Dr. Elizabeth Jaffee explains the challenges facing the scientists developing vaccine-based immunotherapy for pancreatic cancer.